Comments on: Dendreon Saga Nears Climax, Gregoire Biotech Fund in Jeopardy, UW’s Biofuel Futurist, & More Seattle-Area Life Sciences News http://www.xconomy.com/seattle/2009/04/09/dendreon-saga-nears-climax-gregoire-biotech-fund-in-jeopardy-uws-biofuel-futurist-more-seattle-area-life-sciences-news/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 09:14:03 +0000 hourly 1 http://wordpress.org/?v=3.0.4 By: Dr. L http://www.xconomy.com/seattle/2009/04/09/dendreon-saga-nears-climax-gregoire-biotech-fund-in-jeopardy-uws-biofuel-futurist-more-seattle-area-life-sciences-news/comment-page-1/#comment-53327 Dr. L Sun, 12 Apr 2009 20:44:51 +0000 http://www.xconomy.com/?p=19592#comment-53327 If Dendreon had definitive clinical data that proved Provenge met the FDA's established criteria at this very moment, why would the company wait until April 28th to announce these life prolonging findings at the AUA's convention. Is not 'quality of life' to the terminally ill their legacy. If Dendreon had definitive clinical data that proved Provenge met the FDA’s established criteria at this very moment, why would the company wait until April 28th to announce these life prolonging findings at the AUA’s convention.

Is not ‘quality of life’ to the terminally ill their legacy.

]]>